Trial Profile
FK506 Phase 3 Study: a Study for Steroid Non-Resistant Myasthenia Gravis (MG) Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Myasthenia gravis
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 30 Mar 2014 New trial record